From Barrier Dysfunction to Biologic Breakthroughs – Advances in Airway Allergy and Infection: EAACI 2025

THE European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025, held in Glasgow, UK, brought together thousands of clinicians, researchers, and industry leaders in the field of allergy, asthma, and clinical immunology. With a diverse programme spanning planetary health, precision medicine, and epithelial science, the Congress offered a rich platform to discuss cutting-edge advances in diagnosis and treatment. Among the many highlights, sessions focusing on antimicrobial allergy delabelling, epithelial barrier dysfunction, and targeted biologic therapies in chronic rhinosinusitis drew particular attention for their clinical relevance and translational potential.